Negar Niki Alami

5PUBLICATIONS
35CO-AUTHORS
Pharmaceutical delivery technologiesMajor global burdens of diseasePharmacogenomicsCommunity ecology (excl. invasive species ecology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 01, 2026
Dose Selection for Ceftibuten Combined with Avibactam Tomilopil, a Potential Oral Alternative to Carbapenems for Patients with Complicated Urinary Tract Infections.

|Aug 01, 2026
Utilizing Virtual Clinical Trials to Inform Target Coverage That Drives RSV Antiviral Efficacy.

|Jul 11, 2026
A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study.

|Jul 10, 2023
A Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activity.

Negar Alami, David C Carter, Nisha V Kwatra

|May 31, 2021
Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials.

Jeong Heo, Yoon Jun Kim, Jin-Woo Lee

Pageof 1

Frequent Collaborators

2 joint publications

Siddhee A Sahasrabudhe

2 joint publications

Ravi Shankar P Singh

1 joint publications

Jeong Heo

1 joint publications

Yoon Jun Kim